コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ilk for children might not lower the risk of childhood obesity.
2 h a potential reduction of the later risk of childhood obesity.
3 disorder, to attention deficit disorder and childhood obesity.
4 pathways involved in the pathophysiology of childhood obesity.
5 ental media monitoring in efforts to prevent childhood obesity.
6 nments to make them more walkable may reduce childhood obesity.
7 is potentially a modifiable risk factor for childhood obesity.
8 tervening on multiple levels of influence on childhood obesity.
9 as a target for the effective prevention of childhood obesity.
10 strogens, flame retardants, heavy metals and childhood obesity.
11 n intakes could contribute to a reduction in childhood obesity.
12 ages 0 to 23 months is associated with early childhood obesity.
13 ic disparities exist across risk factors for childhood obesity.
14 phthalate concentrations and prevalences of childhood obesity.
15 od has a potential for primary prevention of childhood obesity.
16 re prevalent in conjunction with the rise in childhood obesity.
17 ironmental toxicant can be a risk factor for childhood obesity.
18 ectronic tool to predict an infant's risk of childhood obesity.
19 loci associated with the pathophysiology of childhood obesity.
20 magnetic fields (MFs) increases the risk of childhood obesity.
21 the scope and potency of PAC treatments for childhood obesity.
22 ected because of the increased prevalence of childhood obesity.
23 hanges may have influenced the prevalence of childhood obesity.
24 and obesity, particularly as they relate to childhood obesity.
25 eview focuses on the genetic contribution to childhood obesity.
26 dered relevant factors for the prevention of childhood obesity.
27 xamine the perinatal risk factors related to childhood obesity.
28 s and plant-based diets in the prevention of childhood obesity.
29 birth weight, was the strongest predictor of childhood obesity.
30 heavy smoking was positively associated with childhood obesity.
31 ion years and ADHD show genetic overlap with childhood obesity.
32 infant feeding method, and for their link to childhood obesity.
33 ciation between smoking during pregnancy and childhood obesity.
34 e physical and mental health consequences of childhood obesity.
35 ity plays a critical role in the increase in childhood obesity.
36 c Islanders, smoking was not associated with childhood obesity.
37 Television viewing is associated with childhood obesity.
38 ategies that promote fetal growth and reduce childhood obesity.
39 ntial in battling the increasing epidemic of childhood obesity.
40 olemia is associated with the development of childhood obesity.
41 e of early intervention in the prevention of childhood obesity.
42 mising, population-based approach to prevent childhood obesity.
43 d as weight/height, is often used to monitor childhood obesity.
44 lly contribute to reducing the prevalence of childhood obesity.
45 g, but complex approach to the prevention of childhood obesity.
46 3 loci were associated with birth weight and childhood obesity.
47 inks containing added sugar), contributes to childhood obesity.
48 ehavior in later life and is associated with childhood obesity.
49 influence risk for chronic disease including childhood obesity.
50 ention delivery and training initiatives for childhood obesity.
51 ancy is unlikely to be a main contributor to childhood obesity.
52 d make a meaningful contribution to reducing childhood obesity.
53 asthma medication use on the development of childhood obesity.
54 e, during infancy is associated with risk of childhood obesity.
55 that of underlying infection on the risk of childhood obesity.
56 rum antibiotics were associated with risk of childhood obesity.
57 ion of metabolic homeostasis contributing to childhood obesity.
58 ncreased risk of rapid growth in infancy and childhood obesity.
59 ests that air pollution is a risk factor for childhood obesity.
60 e, during infancy is associated with risk of childhood obesity.
61 FM4 associated with adult body mass index or childhood obesity.
62 s associated with an increased risk of early childhood obesity.
63 hild health and decreasing the prevalence of childhood obesity.
64 s a first step towards primary prevention of childhood obesity.
65 dered when implementing strategies to combat childhood obesity.
66 s has been associated with increased risk of childhood obesity.
67 terventions improved the quality of care for childhood obesity.
68 forcers may have a protective effect against childhood obesity.
69 ignificant contribution to the prevention of childhood obesity.
72 ciation between smoking during pregnancy and childhood obesity across race/ethnicity categories merit
75 AMILIA Study was designed to genetically map childhood obesity and associated biological processes in
76 association between breastfeeding and later childhood obesity and blood pressure (BP) is inconsisten
78 of measures to reduce the global epidemic of childhood obesity and encourage mechanistic studies.
79 t previous studies have focused primarily on childhood obesity and have been hampered by limited cont
80 have attempted to elucidate the etiology of childhood obesity and have increased our understanding o
81 ios (ORs) (95% confidence intervals [CI]) of childhood obesity and hyperglycemia associated with diff
83 hite matter (WM) damage has been reported in childhood obesity and in metabolic syndrome (MetS) but m
84 is implicated in clinical conditions such as childhood obesity and increased marrow adiposity in type
85 and validate equations for the prediction of childhood obesity and integrate them into a mobile phone
86 s considered the gold-standard treatment for childhood obesity and is provided to the parent and chil
87 d beverages is seen as one measure to tackle childhood obesity and is under active consideration by t
88 be implemented to decrease the prevalence of childhood obesity and its cardiovascular consequences in
89 amilia Study was designed to genetically map childhood obesity and its comorbidities in the Hispanic
91 mothers with obesity have a greater risk for childhood obesity and metabolic diseases; however, the u
92 micals may play a role in the development of childhood obesity and metabolic disorders, especially wh
94 pporting the role of neighborhood factors on childhood obesity and obesity-related behaviors, much wo
96 Additional strategies are needed to reduce childhood obesity and related disparities among these un
99 o smoke and NRP contribute to development of childhood obesity and suggest that combined exposures ma
100 regarding the prevention of infant and early childhood obesity and to identify research gaps and oppo
103 at IL-17(+) MAIT cells are also increased in childhood obesity, and altered MAIT cell frequencies in
104 der of importance, the main risk factors for childhood obesity are being unfit, having an obese fathe
105 emographic-socioeconomic characteristics and childhood obesity are complex in the United States.
110 of adipokines and inflammatory molecules in childhood obesity are well documented, the contribution
111 recessive disorder that is characterized by childhood obesity associated with hyperinsulinemia, chro
113 l surface expression of all the 14 described childhood obesity-associated MC4R missense mutations.
114 ns for the potential pharmacologic rescue of childhood obesity-associated MC4R mutations and for the
115 se mutant receptors, in addition to 11 other childhood obesity-associated MC4R mutations, indicates t
116 her examine the functional defects caused by childhood obesity-associated MC4R mutations, we develope
118 9 +/- 1.5 and 12 +/- 1.5 months) for risk of childhood obesity (BMI at 2 years >91(st) centile and we
120 revious studies, we addressed CNVs in common childhood obesity by examining children with a BMI in th
122 ohort of 1080 defined European American (EA) childhood obesity cases and 2500 lean controls (< 50(th)
125 ntinued to show association when two extreme childhood obesity cohorts were included (2,214 cases and
127 ncy was associated with an increased risk of childhood obesity compared with controls without infecti
130 he question as to whether the monocytosis in childhood obesity contributes to atherogenesis over the
135 an association between plant-based diets and childhood obesity does not mean that such diets should n
136 isorder characterized by neonatal hypotonia, childhood obesity, dysmorphic features, hypogonadism, me
137 ated for decades, the emerging links between childhood obesity, early onset puberty, and adult metabo
138 been one of the most robust risk factors for childhood obesity, effects of specific parenting influen
141 pment in genetically stable populations, the childhood obesity epidemic can be primarily attributed t
149 are generally cost effective for preventing childhood obesity, existing evidence suggests that nutri
150 t drop stems from the concurrent increase in childhood obesity, few longitudinal studies of growth an
151 ve previously described a women with extreme childhood obesity (Fig. 1), abnormal glucose homeostasis
152 ng was independently associated with reduced childhood obesity for both HIV-exposed and unexposed chi
158 it the most dramatic phenotype, showing that childhood obesity has consequences on intestinal IEL see
168 e found substantially greater achievement of childhood obesity HEDIS measures in the CDS arm (adjuste
169 findings advance etiologic understanding of childhood obesity, highlighting complex effects of SES o
170 deficits and by metabolic defects including childhood obesity, hyperinsulinemia and Type 2 diabetes.
173 city-specific association of phthalates with childhood obesity in a nationally representative sample.
174 ents of pentaBDE mixture was associated with childhood obesity in a population of Latino children par
175 ng the association between breastfeeding and childhood obesity in an African setting with high HIV pr
177 ion would be a promising strategy to prevent childhood obesity in humans, but more research is clearl
178 n that among adults, the rate of increase in childhood obesity in many countries has been greater tha
181 bute to the genetic susceptibility of common childhood obesity in subjects of both European and Afric
185 Actions to be considered for preventing childhood obesity include the promotion of healthy mater
188 during the past year in the following areas: childhood obesity, insulin resistance, dyslipidemia, hyp
211 breastfeeding to reduced risk of developing childhood obesity is inconclusive, yet previous studies
219 ere is now growing evidence that the risk of childhood obesity is strongly influenced by perinatal de
223 helps to understand why, particularly during childhood, obesity is a risk factor for the development
224 acid signature significantly associated with childhood obesity, is an independent risk factor of futu
225 , hay fever or eczema), alcohol consumption, childhood obesity, low-density lipoprotein cholesterol (
228 e, genetic and environmental factors driving childhood obesity may have a lasting influence on health
229 In the context of other options for treating childhood obesity, metformin has not been shown to be cl
230 al degeneration, sensorineural hearing loss, childhood obesity, non-insulin-dependent diabetes mellit
234 of this study was to determine the effect of childhood obesity on skeletal mass and dimensions relati
235 ng or nicotine exposure during pregnancy and childhood obesity or metabolic disorders at any age.
236 etween maternal smoking during pregnancy and childhood obesity or whether this association varies by
239 NPs being associated with common early-onset childhood obesity (P = 0.0003) and common adult morbid o
242 App, thereby providing proof of concept that childhood obesity prediction research can be integrated
243 gh extensive descriptive research shows that childhood obesity predisposes a person to adult obesity,
244 uring the coronavirus disease 2019 pandemic, childhood obesity prevalence has reached unprecedented l
245 data suggest that the spiralling increase in childhood obesity prevalence might be abating; increased
251 ios for obesity in adulthood associated with childhood obesity ranged from 1.3 (95 percent confidence
254 l analyses (n = 10,583), the odds for severe childhood obesity reached 1.30 (P = 8.0 x 10(-11)).
255 This genetic risk expresses itself early as childhood obesity, reinforcing the notion that early pre
266 e exposure to bisphenol A (BPA) may increase childhood obesity risk, but few prospective epidemiologi
270 y warrants further investigation, addressing childhood obesity should be an urgent public health prio
274 he science for understanding the etiology of childhood obesity, the preventive interventions and trea
275 revalence, health consequences, and costs of childhood obesity, there has been substantial interest i
277 adolescents, the IOTF convened a workshop on childhood obesity to determine the most appropriate meas
278 interprets data on the early determinants of childhood obesity to provide relevant strategies for dai
279 genetic correlations have been found between childhood obesity traits and birth weight (a proxy for i
280 re identified: never obese (never-OB); early childhood obesity transitioning to non-obesity before ad
281 ssociation have released recommendations for childhood obesity treatment and prevention which include
282 ehavioral treatment (FBT) is recommended for childhood obesity treatment; however, it is not effectiv
283 tudy and 3 European cohort studies (European Childhood Obesity Trial, Norwegian Human Milk Study, and
284 cted the monocyte gene expression profile in childhood obesity using an Illumina microarray platform
285 ay of early-life environmental exposures and childhood obesity, using an exposome-wide approach.
286 ic effects of ART exposure in the context of childhood obesity warrants further investigation, addres
287 regulation of monocyte IMPDH2 and TMEM134 in childhood obesity was also observed in obese adults.
290 our ongoing genome-wide association study on childhood obesity, we demonstrate that ATOM increases th
292 additional genetic variants associated with childhood obesity, we performed a trans-ancestral meta-a
294 Rapid infancy weight gain is associated with childhood obesity, whereas low infancy weight is associa
295 e the impact of maternal prepregnancy BMI on childhood obesity, which warrants further investigation
297 5 differentially regulated monocyte genes in childhood obesity with obesity and complexity of coronar
298 ntribute to malnutrition and rising rates of childhood obesity, with effects throughout the life cour
299 etween antibiotic use in infancy and risk of childhood obesity, with implications for health-care del
300 dvise reduced milk-fat consumption to reduce childhood obesity, yet the relation between lower milk f